Flap design, tension-free primary closure, and suturing — plus a decision tool for managing soft-tissue dehiscence and membrane/graft exposure. Passive, tension-free closure is the single strongest predictor of uneventful GBR healing.
Most wound complications trace back to tension, compromised blood supply, or an over-contoured graft. Build the closure around passivity and flap vascularity.
Principle
Tension-free passivity
The flap must rest over the site without retracting
Test passivity before suturing
Strongest predictor of GBR success
Tension → dehiscence & exposure
Principle
Flap design & blood supply
Full-thickness; base wider than margin
Papilla-sparing where esthetic
Divergent vertical releasing past the MGJ
Avoid incisions over the graft/membrane
Principle
Flap advancement
Periosteal releasing incision at flap base
Shallow (~0.5 mm) — through periosteum only
Blunt undermining to mobilize
Caution near the mental nerve
Principle
Suturing
Horizontal mattress for eversion + seal
Interrupted sutures to approximate margins
Tension borne by mattress, not margin
Remove non-resorbable sutures ~7–14 days
02 — Decision Pathway
Managing dehiscence & exposure
When a wound opens, the management hinges on two questions: is a barrier membrane exposed, and is there infection? Identify the scenario to see the recommended protocol.
Tap the scenario that matches your post-op finding.
Step 1 — Characterize the exposure
RESORBABLE
Small dehiscence, resorbable (collagen) membrane, no pus
Collagen tolerates limited exposure.
d-PTFE
Exposed high-density PTFE, no infection
Dense, low-porosity membrane.
INFECTED
Any membrane + suppuration / spreading infection
Pus, pain, swelling, e-PTFE exposure.
NO BARRIER
Flap dehiscence / cover-screw exposure, no membrane
Soft-tissue opening over graft or implant.
▾
03 — Quick Reference
Suture material selection
Material
Resorbable?
Typical use / notes
ePTFE (e.g., Gore-Tex)
No
Monofilament, low plaque affinity, excellent for GBR/esthetic closure
PTFE (monofilament)
No
Non-wicking, soft-tissue friendly; remove ~10–14 days
Silk (braided)
No
Easy handling but wicks plaque/bacteria — avoid over grafts
Polyglycolic acid / Vicryl
Yes
Braided resorbable; convenient where suture removal is hard
Chromic gut
Yes
Fast resorption; less predictable tensile retention
Sizing: 4-0 for flap body/posterior, 5-0–6-0 for esthetic/papilla approximation. Bear tension on mattress sutures and keep the margin passive.
Reference
Sources & clinical disclaimer
For licensed clinicians — educational use only. This algorithm summarizes published technique and consensus and is not a substitute for individual clinical judgment, examination, or the standard of care in your jurisdiction. Membrane handling and exposure protocols vary by product — follow manufacturer instructions.
Burkhardt R, Lang NP. Coverage of localized gingival recessions / flap tension and wound healing. J Clin Periodontol. 2005;32(3):287–293.
Hur Y, et al. Modified periosteal releasing incision for tension-free flap closure. Clin Adv Periodontics. 2015;5(1):29–34.
Garcia J, et al. Effect of membrane exposure on guided bone regeneration — systematic review & meta-analysis. Clin Oral Implants Res. 2018;29(3):328–338.
Last reviewed: June 2026 · Next review due: June 2027 · Version 1.0
Self-Test
Self-Test
Switch between board-style single-best-answer questions and oral-defense prompts. Commit to an answer before revealing.
1. Which factor is the single most important determinant of uneventful primary wound healing over a GBR site?
B is correct. Passive, tension-free closure is the strongest predictor of GBR success; residual tension is the leading cause of dehiscence and membrane exposure. Membrane choice, suture type, and antibiotics are secondary to achieving a tension-free flap.
2. To advance a mucoperiosteal flap for tension-free closure, the recommended maneuver is:
A is correct. A shallow (~0.5 mm) periosteal releasing incision at the flap base, with blunt undermining, releases the inelastic periosteum and advances the flap. Deep incisions risk hemorrhage/nerve injury; cutting keratinized tissue or papillae harms blood supply and esthetics.
3. A high-density PTFE (d-PTFE) membrane becomes exposed at 2 weeks with no signs of infection. The best initial management is to:
A is correct. d-PTFE has ~0.2 µm pores that resist bacterial ingress and is designed to tolerate exposure. Manage with 0.12% chlorhexidine rinse plus chlorhexidine gel and meticulous hygiene, monitor, and remove at the planned interval. Forcing closure under tension or routine systemic antibiotics is inappropriate.
4. An exposed expanded-PTFE (e-PTFE) membrane now shows suppuration and surrounding erythema. The correct action is to:
B is correct. Porous e-PTFE wicks bacteria once exposed; an infected membrane must be removed promptly with debridement and infection control (culture-guided systemic antibiotics if spreading). Leaving an infected, porous membrane risks loss of the graft and host bone.
1. Walk the examiner through how you achieve tension-free primary closure over a simultaneous GBR site, and how you confirm it.
Model answer. Raise a full-thickness mucoperiosteal flap with a broad base and, where needed, divergent vertical releasing incisions extending past the mucogingival junction to a flexible mucosal base. Make a shallow periosteal releasing incision (~0.5 mm, through periosteum only) at the flap base and bluntly undermine to mobilize the elastic mucosa. Confirm passivity by draping the flap over the site — it should rest there and overlap the opposing margin without being held, and not spring back. Close with horizontal mattress sutures to bear tension and evert the margins, then interrupted sutures to approximate them. Avoid over-contouring the graft, which re-introduces tension.
Examiner follow-ups:
How do you test passivity objectively?
What are the risks of a releasing incision in the posterior mandible?
Why bear tension on mattress rather than margin sutures?
2. A non-resorbable membrane is exposed at the two-week review. Take me through your decision-making.
Model answer. First characterize it: which membrane (dense d-PTFE vs porous e-PTFE) and is there infection (pus, increasing pain/swelling)? A non-infected d-PTFE exposure is managed conservatively — leave it, chlorhexidine rinse and gel, meticulous hygiene, weekly monitoring, and removal at the planned time — because its low porosity resists bacterial ingress. An exposed e-PTFE, or any membrane with suppuration/spreading infection, should be removed promptly with debridement, graft salvage where incorporated, and culture-guided systemic antibiotics if there are systemic signs. Document and reset expectations on regenerated volume.
Examiner follow-ups:
Why does d-PTFE tolerate exposure but e-PTFE does not?
When would you start systemic antibiotics?
How does exposure affect the final bone gain?
3. Compare resorbable and non-resorbable membranes with respect to exposure risk and its consequences, and how that informs your choice.
Model answer. Resorbable collagen membranes carry a lower overall complication burden — exposures are often self-limiting, heal by secondary intention, and need no removal surgery — but they provide weaker space maintenance and are best for contained/horizontal defects. Non-resorbable membranes (d-PTFE, titanium-reinforced PTFE) maintain space far better for vertical and large defects, but exposure is more consequential: e-PTFE in particular wicks bacteria and risks infection, and all require a second-stage removal. So I select collagen for contained defects favoring uneventful healing, and reserve titanium-reinforced/d-PTFE for demanding space-maintenance cases where I can secure robust tension-free primary closure.
Examiner follow-ups:
Which membrane would you choose for vertical augmentation, and why?
How much does exposure reduce regenerated bone volume?
What flap/closure modifications reduce exposure risk for non-resorbable membranes?